Simulations Plus, Inc. (SLP)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Simulations Plus, Inc. (SLP)
Go deeper and ask any question about SLP
Company Performance
Current Price
as of Sep 13, 2024$32.50
P/E Ratio
68.48
Market Cap
$650.25M
Description
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
Metrics
Overview
- HQLancaster, CA
- SectorTechnology Services
- IndustryPackaged Software
- TickerSLP
- Price$32.5+0.78%
Trading Information
- Market Cap$650.25M
- Float81.56%
- Average Daily Volume (1m)117,513
- Average Daily Volume (3m)149,113
- EPS$0.48
Company
- Revenue$66.98M
- Rev Growth (1yr)14.23%
- Net Income$3.14M
- Gross Margin71.49%
- EBITDA Margin16.95%
- EBITDA$3.14M
- EV$867.64M
- EV/Revenue12.95
- P/E68.48
- P/S9.91
Documents
SEC Filings
Earnings Calls
Factset Street Account